Quick Answer
Climb Bio, Inc. reported Net Income of -$59.85 million for fiscal year 2025.
Climb Bio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$59.85M | +19.0% |
| 2024 | -$73.90M | -110.4% |
| 2023 | -$35.12M | +22.4% |
| 2022 | -$45.24M | +4.7% |
| 2021 | -$47.48M | -129.7% |
| 2020 | -$20.67M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.89M | -44.9% | -48.7% |
| June 30, 2025 | -$8.67M | +84.2% | +58.3% |
| March 31, 2025 | -$20.78M | -1124.6% | -133.6% |
| September 30, 2024 | -$8.89M | -124.2% | +83.8% |
| June 30, 2024 | -$54.89M | -951.5% | -3134.5% |
| March 31, 2024 | -$1.70M | +92.4% | +57.2% |
| September 30, 2023 | -$3.97M | +59.0% | +24.0% |
| June 30, 2023 | -$5.22M | +64.2% | +76.6% |
- Climb Bio, Inc. showed an increase of +19.0% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Climb Bio, Inc.’s net income has declined by 189.6% (from -$20.67 million to -$59.85 million).
- The most recent figure is from Climb Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: